UC Davis Health has two clinical trials underway for hospitalized patients with severe COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2. The studies are evaluating the safety and effectiveness of two drugs — the investigational antiviral remdesivir, and sarilumab, a drug that blocks the body’s acute inflammatory response.
Anticipating a scarcity of medical devices and a lack of treatment options for COVID-19, UC Davis College of Engineering researchers are investigating innovative technology to manufacture masks, ventilators and other critical equipment.
The Office of Research has launched a COVID-19 Research Working Group to help faculty, postdocs and students connect with collaborators and funding opportunities.